Literature DB >> 8234197

Interaction between chemicals and melanin.

B S Larsson1.   

Abstract

Various drugs and other chemicals, such as organic amines, metals, polycyclic aromatic hydrocarbons, etc., are bound to melanin and retained in pigmented tissues for long periods. The physiological significance of the binding is not evident, but it has been suggested that the melanin protects the pigmented cells and adjacent tissues by adsorbing potentially harmful substances, which then are slowly released in nontoxic concentrations. Long-term exposure, on the other hand, may build up high levels of noxious chemicals, stored on the melanin, which ultimately may cause degeneration in the melanin-containing cells, and secondary lesions in surrounding tissues. In the eye, e.g., and in the inner ear, the pigmented cells are located close to the receptor cells, and melanin binding may be an important factor in the development of some ocular and inner ear lesions. In the brain, neuromelanin is present in nerve cells in the extrapyramidal system, and the melanin affinity of certain neurotoxic agents may be involved in the development of parkinsonism, and possibly tardive dyskinesia. In recent years, various carcinogenic compounds have been found to accumulate selectively in the pigment cells of experimental animals, and there are many indications of a connection between the melanin affinity of these agents and the induction of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234197     DOI: 10.1111/j.1600-0749.1993.tb00591.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  54 in total

Review 1.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

2.  Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.

Authors:  John L Joyal; John A Barrett; John C Marquis; Jianqing Chen; Shawn M Hillier; Kevin P Maresca; Marie Boyd; Kenneth Gage; Sridhar Nimmagadda; James F Kronauge; Matthias Friebe; Ludger Dinkelborg; James B Stubbs; Michael G Stabin; Rob Mairs; Martin G Pomper; John W Babich
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

3.  Zinc uptake and storage: the role of fundus pigmentation.

Authors:  Despina Kokkinou; Haino Uwe Kasper; Tobias Schwarz; Karl Ulrich Bartz-Schmidt; Ulrich Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 4.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

5.  Serum-free cultivation of adult normal human choroidal melanocytes.

Authors:  Monika Valtink; Katrin Engelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-26       Impact factor: 3.117

Review 6.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 7.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 8.  Chemiexcitation and Its Implications for Disease.

Authors:  Douglas E Brash; Leticia C P Goncalves; Etelvino J H Bechara
Journal:  Trends Mol Med       Date:  2018-05-08       Impact factor: 11.951

9.  A scanning electron microscope study of the pecten oculi of the black kite (Milvus migrans): possible involvement of melanosomes in protecting the pecten against damage by ultraviolet light.

Authors:  S G Kiama; J Bhattacharjee; J N Maina; K D Weyrauch
Journal:  J Anat       Date:  1994-12       Impact factor: 2.610

10.  Supernormal electro-oculograms in patients with neurofibromatosis type 1.

Authors:  Wojciech Lubiński; Stanisław Zajaczek; Zbigniew Sych; Krzysztof Penkala; Olgierd Palacz; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2004-09-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.